Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
140 participants
INTERVENTIONAL
2018-03-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
NCT06049160
Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
NCT03723031
Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section
NCT05928871
Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?
NCT02509351
Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss
NCT02083107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preoperative misoprostol group
70 women who received 600 mg misoprostol rectally preoperatively before cesarean section
rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre
postoperative misoprostol group
70 women who received 600 mg misoprostol postoperatively at operating theatre after cesarean section
rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rectal misoprostol 600mg
70 women who received 600 mg misoprostol postoperatively at operating theatre
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No contraindications to prostaglandins.
* Have no history of coagulopathy.
Exclusion Criteria
* Maternal hypertension.
* Diabetes mellitus.
* Previous CS and those with active labor.
* Multiple Fibroid uterus.
* Multiple pregnancies or polyhydramnios.
* Previous myomectomy, previous history of PPH.
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
sarah mohamed hassan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sarah mohamed hassan
lecturer of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr El Ainiy Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1122345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.